2025
Daniel Drucker
Breakthrough Prize recognizes Daniel Drucker for work leading to diabetes, anti-obesity drugs
2025
Breakthrough Prize recognizes Daniel Drucker for work leading to diabetes, anti-obesity drugs
“Daniel Drucker, the Canadian scientist renowned for discoveries that sparked the advent of Ozempic and other GLP-1 medicines for diabetes and obesity, has added yet another accolade to his growing collection: the 2025 Breakthrough Prize in Life Sciences.
With a total of six $3-million prizes and billed as the “Oscars of Science,” Breakthrough Prizes are awarded by leading Silicon Valley entrepreneurs in recognition of transformative advances in life sciences, fundamental physics and mathematics.
Drucker, a senior investigator at the Lunenfeld-Tanebaum Research Institute (LTRI) at Sinai Health and University Professor of medicine in the University of Toronto’s Temerty Faculty of Medicine, shared a $3-million life sciences prize with Joel Habener of Harvard University, Jens Juul Holst of the University of Copenhagen, Svetlana Mojsov of Rockefeller University and Lotte Bjerre Knudsen of Novo Nordisk.”
Published by Jovana Drinjakovic, U of T News
